Healthy Workers company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

healthyworkers.nl

Founded Year

2015

Stage

Seed - II | Alive

Total Raised

$2.29M

Last Raised

$1.7M | 3 yrs ago

About Healthy Workers

Healthy Workers helps large companies gain insight into employee well-being and the quality of life in the office building to provide so-called "interventions" that provide a pleasant working environment and happier employees.

Healthy Workers Headquarter Location

Johan Huizingalaan 400-2

Amsterdam, 1066 JS,

Netherlands

(06) 22 94 29 98

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Healthy Workers

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Healthy Workers is included in 1 Expert Collection, including HR Tech.

H

HR Tech

4,016 items

HR tech startups are helping companies manage critical pain points in HR processes such as recruitment, automation, career development, compensation, and benefits management, through a mix of software and services.

Latest Healthy Workers News

Research Centers of America Begins Recruiting Healthy Workers for COVID-19 Vaccine Clinical Trial

Aug 4, 2020

News provided by Share this article HOLLYWOOD, Fla., Aug. 4, 2020 /PRNewswire/ -- Research Centers of America (RCA), Broward County's largest independent research site, is currently conducting COVID-19 vaccine trials, implemented under Operation Warp Speed (OWS). RCA is recruiting volunteers to participate in these clinical trials, working with the Federal Government and many major Pharmaceutical Companies, which developed a vaccine to potentially prevent COVID-19. Dr. Howard Schwartz, Chief Medical Officer at Research Centers of America, met with several news media channels and was also part of a roundtable discussion with Vice President Mike Pence, school leaders and members of the Miller School of Medicine, along with several other researchers working to end the ongoing battle against the Coronavirus. The first trial will be for Moderna, which is expected to enroll approximately 30,000 participants in the United States. RCA will recruit between 300 to 500 participants for Moderna's trial alone. Moderna (July 27th Press Release):  "The Phase 3 study protocol follows the U.S. Food and Drug Administration (FDA) guidance on clinical trial design for COVID-19 vaccine studies. The randomized, placebo-controlled trial is expected to include approximately 30,000 participants in the United States, testing an mRNA-1273 dosage of 100 µg. The primary endpoint will be the prevention of symptomatic COVID-19 disease. Key secondary endpoints include prevention of severe COVID-19 disease (as defined by the need for hospitalization) and prevention of infection by SARS-CoV-2 regardless of symptomology. SARS-CoV-2 is the virus that causes COVID-19. The primary efficacy analysis of the Phase 3 study will be an event-driven analysis, based on the number of participants with symptomatic COVID-19 disease. To ensure the ongoing safety and monitoring of the participants in the trial, data will be reviewed by an independent Data and Safety Monitoring Board organized by NIAID throughout the study. The  clinicaltrials.gov  identifier is NCT04470427. "  Research Centers of America is honored and excited to begin this process and to be a part of the fight against the Coronavirus, which has dramatically affected the entire world we live in. RCA is using every possible channel and means at their disposal to inform and involve the community in this important mission and study. Dr. Howard Schwartz, Chief Medical Officer at Research Centers of America, met with several news media channels and was also part of a roundtable discussion with Vice President Mike Pence, school leaders and members of the Miller School of Medicine, along with several other researchers working to end the ongoing battle against the Coronavirus. "Today is a day of hope," Pence concluded. "Today is a day of promise. If all of us continue to do all we can, we're going to reach the day when we put this coronavirus behind us. "  About RCA:  RCA is an independently owned and operated research company. RCA specializes in conducting Phase I-IV vaccines and CNS trials for pharmaceutical and biotech companies. At RCA we are committed to delivering solid science and applying strict adherence to GCP/ICH, as well as training according to FDA Code of Federal Regulations. Committed to the integrity and quality of our work, RCA delivers accurate results and aims to exceed our goals in medical advancement. RCA team members have been leaders in the clinical trial industry for the past 25 years, successfully executing over 1000 research studies across multiple therapeutic areas. Dr. Schwartz has done approximately 250 vaccine trials. The clinical team has built a solid reputation over the years by dedicating themselves to be a truly exceptional, first-in-class, independently owned and operated clinical research site - which consistently sets RCA apart from the standard. Research Centers of America - DISCOVERING NEW TREATMENTS AND CHANGING LIVES. 7261 Sheridan Street, Suite 210,  Hollywood, FL 33024

  • When was Healthy Workers founded?

    Healthy Workers was founded in 2015.

  • Where is Healthy Workers's headquarters?

    Healthy Workers's headquarters is located at Johan Huizingalaan 400-2, Amsterdam.

  • What is Healthy Workers's latest funding round?

    Healthy Workers's latest funding round is Seed - II.

  • How much did Healthy Workers raise?

    Healthy Workers raised a total of $2.29M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.